Catriona A. Ford

Cancer Research UK — United Kingdom

Immunology and Microbiology · Life Sciences

14h-index1.4kcitations64works1.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Phagocytosis and Immune Regulation(16), Melanoma and MAPK Pathways(14), Pancreatic and Hepatic Oncology Research(12), Protein Degradation and Inhibitors(10), Cancer, Hypoxia, and Metabolism(8)

Publications64 total

MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance

2 cited

Nature·2025· 2 citedOpen Access

Hepatic zonation determines tumorigenic potential of mutant β-catenin

2 cited

Nature·2025· 2 citedOpen Access

Figure 5 from Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma

2025Open Access

Data from Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma

2025Open Access

Supplementary Figures S1-S10 from Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma

2025Open Access

Supplementary Table S1 from Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma

2025Open Access

Figure 4 from Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma

2025Open Access

Figure 2 from Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma

2025Open Access

Figure 3 from Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma

2025Open Access

Supplementary Table S1 from Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma

2025Open Access

Supplementary Figures S1-S10 from Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma

2025Open Access

Supplementary Table S2 from Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma

2025Open Access

Supplementary Table S2 from Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma

2025Open Access

SOX2 empowers a rapid tumorigenic programme from the tumour-resistant population in the skin

2025Open Access

Supplementary Figure 2 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

2025Open Access

Supplementary Figure 4 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

2025Open Access

Supplementary Figure 3 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

2025Open Access

Figure 1 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

2025Open Access

Data from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

2025Open Access

Supplementary Figure 1 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

2025Open Access

page 1 of 4Next →

Frequent Co-authors

Owen J. Sansom(40), Colin Nixon(30), Andrew D. Campbell(30), Kathryn Gilroy(27), Simon T. Barry(23), Nikola Vlahov(15), William Clark(14), Arafath K. Najumudeen(13), Nathalie Sphyris(12), Laura M. Millett(11), Valeria Pavet(11), Philip D. Dunne(11), Sigrid K. Fey(10), Jennifer P. Morton(10), Dana Koludrović(10), Patricia P. Centeno(10), Mona Foth(10), Elpida Tsonou(10), Courtney Bull(10), Bryan Serrels(10)